Literature DB >> 10751789

Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial.

.   

Abstract

There has been debate regarding the issue of whether ischemic preconditioning is effective in the aging and diseased heart. Therefore, we retrospectively analyzed the effect of preinfarction angina in patients less than versus greater than 60 years of age in the TIMI 4 study. Preinfarction angina was defined as an episode of typical angina pectoris that occurs prior to the time of index chest pain associated with the myocardial infarction itself. Patients who were 60 years and older had a higher rate of death and the combined endpoints of death, heart failure/shock, and/or reinfarction compared with younger patients. However, patients 60 years or older who had preinfarction angina had lower rates of the combined endpoints of death, heart failure/shock, and/or reinfarction (11%) compared with patients without angina (23%; P = 0.04). They also had lower creatine kinase (CK) values. Therefore, preinfarction angina was protective in patients 60 years or older in the TIMI 4 study.

Entities:  

Year:  1998        PMID: 10751789     DOI: 10.1023/A:1008833101817

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  25 in total

1.  Preconditioning of human myocardium with adenosine during coronary angioplasty.

Authors:  M A Leesar; M Stoddard; M Ahmed; J Broadbent; R Bolli
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

2.  Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts.

Authors:  M Tani; Y Suganuma; H Hasegawa; K Shinmura; Y Hayashi; X Guo; Y Nakamura
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

3.  Preconditioning the human myocardium.

Authors:  D M Yellon; A M Alkhulaifi; W B Pugsley
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

4.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.

Authors:  E Deutsch; M Berger; W G Kussmaul; J W Hirshfeld; H C Herrmann; W K Laskey
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

5.  Improvement in ischemic parameters during repeated exercise testing: a possible model for myocardial preconditioning.

Authors:  S Maybaum; M Ilan; J Mogilevsky; D Tzivoni
Journal:  Am J Cardiol       Date:  1996-11-15       Impact factor: 2.778

6.  Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?

Authors:  R A Kloner; T Shook; K Przyklenk; V G Davis; L Junio; R V Matthews; S Burstein; M Gibson; W K Poole; C P Cannon
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

7.  Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model.

Authors:  M E Speechly-Dick; G J Grover; D M Yellon
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

8.  Effect on short-term prognosis and left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction.

Authors:  T Anzai; T Yoshikawa; Y Asakura; S Abe; T Meguro; M Akaishi; H Mitamura; S Handa; S Ogawa
Journal:  Am J Cardiol       Date:  1994-10-15       Impact factor: 2.778

9.  Preconditioning does not prevent postischemic dysfunction in aging heart.

Authors:  P Abete; N Ferrara; A Cioppa; P Ferrara; S Bianco; C Calabrese; F Cacciatore; G Longobardi; F Rengo
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

10.  Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia.

Authors:  J S Ikonomidis; L C Tumiati; R D Weisel; D A Mickle; R K Li
Journal:  Cardiovasc Res       Date:  1994-08       Impact factor: 10.787

View more
  3 in total

Review 1.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 2.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

3.  Pre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey.

Authors:  Luc Lorgis; Aurélie Gudjoncik; Carole Richard; Laurent Mock; Philippe Buffet; Philippe Brunel; Luc Janin-Manificat; Jean-Claude Beer; Damien Brunet; Claude Touzery; Luc Rochette; Yves Cottin; Marianne Zeller
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.